Presence of a Large Number of Market Players is contributing to the Growth of the US Brachytherapy Market

The US brachytherapy market is anticipated to grow at a CAGR of 3.1% during the forecast period (2021-2027). The presence of major brachytherapy system providers in the US is contributing to the highest market share of the country. Best Medical International, Inc., AngioDynamics, Inc., Isoray, Inc. Boston Scientific Corp., Hologic, Inc., and iCAD, Inc. are some of the key contributors to the market growth. 

Browse the full report description US Brachytherapy Market Size, Share & Trends Analysis Report by Indication (Breast Cancer, Gynecological Cancer, Prostate Cancer, Skin Cancer, Brain Cancer, and Others), and by Type (Low-Dose Rate (LDR) Brachytherapy and High-Dose Rate (HDR) Brachytherapy) Forecast Period, 2020-2026 at https://www.omrglobal.com/industry-reports/us-brachytherapy-market

Companies are focused on research to provide advanced brachytherapy systems. For instance, in June 2020, Isoray, Inc., the producer of Cesium-131 brachytherapy seeds entered into a research grant agreement with the University of Cincinnati Physicians Company for a study involving the treatment of recurrent head and neck cancers. The research trial aimed to evaluate the safety and early effectiveness of the addition of pembrolizumab (Keytruda) to the regimen of Cesium-131 with surgical resection. 

In March 2021, the research had concluded the primary findings of this study which includes the fact that re-treatment of recurrent head and neck cancers with surgical resection and Cesium-131 brachytherapy is safe and feasible. This finding is especially important due to the potential difficulties that follow re-irradiation of recurrent head and neck cancer using external beam radiation therapy (EBRT). Such research showing future potential for combination therapy is expected to contribute to market growth during the forecast period.

Market Coverage

• The market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- 

o By Indication

o By Type

• Competitive Landscape- AngioDynamics, Inc., General Electric Co., Hologic, Inc., Isoray, Inc., Sensus Healthcare, Inc., Sun Nuclear Corp.

Key Questions Addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

US Brachytherapy Market Report Segment

By Indication

• Breast Cancer 
• Gynecological Cancer 
• Prostate Cancer 
• Skin Cancer
• Brain Cancer 
• Others

By Type

• Low-Dose Rate (LDR) Brachytherapy
• High-Dose Rate (HDR) Brachytherapy